Proteomics receives $1.2 million in R&D tax incentive
Filed with ASX · · 1 page · English
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- PromarkerD distribution network expands to Britain
- PromarkerD outperforms standard of care tests for DKD
- Proteomics awarded $100,000 manufacturing funding
- September 2021 Quarterly Activities Report and Appendix 4C
- Clinical utility study shows benefit of PromarkerD testing
Later from Proteomics International Laboratories
- Proteomics secures major pharmacokinetic testing contract
- December 2021 Quarterly Activities Report and Appendix 4C
- Unique panel of biomarkers identified for oesophageal cancer
- PromarkerD completes pre-assessment for Medicare rebate
- New Clinical Advisory Board for PromarkerD global rollout
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories